Compared with the tissues of ICC patients sensitive to anti-PD1 therapy, the number of CD8+ cells in the tissues of ICC patients resistant to anti-PD1 therapy was significantly reduced (Fig. 7J). The gene discussed is CD8A; the disease is intrahepatic cholangiocarcinoma.